Trial Profile
Phase I/II Study of Paclitaxel / Carboplatin / RAD001 as First Line Therapy for Advanced Adenocarcinoma of the Stomach
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 04 Apr 2019
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Carboplatin; Paclitaxel
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 31 Mar 2019 Status changed from active, no longer recruiting to completed.
- 20 Feb 2019 Planned End Date changed from 31 Dec 2018 to 31 Dec 2019.
- 20 Feb 2019 Planned primary completion date changed from 31 Dec 2018 to 31 Dec 2019.